SuperSonic Imagine’s Aixplorer® Ultrasound System Delivers Enhanced Liver Imaging to SurgOne, P.C.
April 26 2017 - 2:00AM
Business Wire
Patients at this Denver facility now receive
non-invasive 60-second liver assessment
Regulatory News:
SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814), a
company specializing in ultrasound medical imaging, today announced
the installation of its flagship Aixplorer ultrasound system at
SurgOne, P.C., a comprehensive general surgery group serving
greater Denver. Physicians at SurgOne will use Aixplorer to assess
liver disease and characterize liver tissue in its hepatobiliary
and transplant specialty services.
Real-time ShearWave™ Elastography (SWE™), available only on the
Aixplorer ultrasound system, is a 60-second non-invasive exam that
can be used for imaging patients with liver disease, and does
require a physician’s referral. SWE offers the advantage of
real-time imaging of liver anatomy, while also providing not only a
color-coded map of liver stiffness, but also a quantification tool
for the measurement of an important parameter for liver
diagnostics.
Over 100 international publications have demonstrated the
accuracy, reliability and effectiveness of SuperSonic Imagine’s SWE
in this area.
Less than 2 weeks ago, the results of an international
multicenter study on 1134 patients were published in Hepatology,
and confirmed the benefit of SWE in the non-invasive assesment of
liver fibrosis1, including for patients with diseases such as
hepatitis C that may require repeated follow-up evaluations.
Although biopsy has been considered the standard for assessing
liver fibrosis severity, the drawbacks of this invasive approach
include significant incidence of morbidity, high procedure costs
due to longer hospitalisation, and clinical shortcomings. Fibrosis
is even sometimes underestimated in 10-30% of cases.2,3
“We are proud to bring this innovative imaging platform to our
patients with chronic liver disease. Not only does it allow me to
evaluate liver fibrosis very precisely and reliably, but it also
offers a non-invasive and painless experience for our patients,”
commented Dr. W. Ben Vernon, whose surgical specialties at SurgOne
include transplant and hepatobiliary procedures. SWE is performed
at the SurgOne offices adjacent to HealthOne Presbyterian/St.
Luke's Medical Center.
“SuperSonic Imagine SWE’s highly accurate assessment of liver
stiffness, combined with the known benefit of ultrasound imaging
makes our product a valuable addition to esteemed practices like
SurgOne. We are privileged to work with this facility and others
like it that need innovative diagnostic solutions,” said Alex
Exposito, Director of North America Sales.
1 Assessment of biopsy-proven liver fibrosis by 2D-shear wave
elastography: An individual patient data based meta-analysis.
Herrmann E, de Lédinghen V, Cassinotto C, Chu WC, Leung VY,
Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J,
Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng
J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P,
Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J,
Deffieux T, Friedrich-Rust M. Hepatology. 2017 Mar 31. doi:
10.1002/hep.29179. Le lien PubMed :
https://www.ncbi.nlm.nih.gov/pubmed/283702572 Sampling error and
intraobserver variation in liver biopsy in patients with chronic
HCV infection. Regev A, Berho, M, Jeffers LJ, Milikowski C, Molina
EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Am J
Gastroenterol. 2002 Oct;97(10):2614-8.3 Sources of variability in
histological scoring of chronic viral hepatitis. Rousselet MC,
Michalak S, Dupré F, Croué, A, Bedossa P, Saint-André JP, Calès P;
Hepatitis Network 49. Hepatology. 2005 Feb;41(2):257-64.
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France),
SuperSonic Imagine is a company specializing in medical imaging.
The company designs, develops and markets a revolutionary
ultrasound system, Aixplorer®, with an UltraFast™ platform that can
acquire images 200 times faster than conventional ultrasound
systems. In addition to providing exceptional image quality, this
unique technology is the foundation of several innovations which
have changed the paradigm of ultrasound imaging: ShearWave™
Elastography (SWE™), UltraFast™ Doppler and more recently Angio
PL.U.S – Planewave UltraSensitive™ Imaging.
ShearWave Elastography allows physicians to visualize and
analyze the stiffness of tissue in a real-time, reliable,
reproducible and non-invasive manner. This criteria has become an
important parameter in diagnosing potentially malignant tissue or
other diseased tissue. As of today, over 300 peer-reviewed
publications have demonstrated the value of SWE for the clinical
management of patients with a wide range of diseases. UltraFast
Doppler combines Color Flow Imaging and Pulsed Wave Doppler into
one simple exam, providing physicians with exam results
simultaneously and helping to increase patient throughput. The
latest innovation, Angio PL.U.S, provides a new level of
microvascular imaging through significantly improved color
sensitivity and spatial resolution while maintaining exceptional 2D
imaging.
SuperSonic Imagine has been granted regulatory clearances for
the commercialization of Aixplorer in key global markets.
SuperSonic Imagine is a listed company since April 2014 on the
Euronext, symbol SSI. For more information about SuperSonic
Imagine, please go to www.supersonicimagine.com.
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170425006626/en/
SuperSonic ImagineMarketing & CommunicationEmmanuelle
Vella, +33 4 86 79 03
27emmanuelle.vella@supersonicimagine.comorNewCapInvestor
Relations – EUPierre Laurent / Florent
Alba+33144719855supersonicimagine@newcap.frorPascale
CommunicationMedia Relations - USAmy Phillips, +1 412 327
9499amy@pascalecommunications.com
Stage Stores (NYSE:SSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stage Stores (NYSE:SSI)
Historical Stock Chart
From Apr 2023 to Apr 2024